Welcome to Xeraya Capital
At Xeraya, all of our activities, expertise, and resources focus solely on the Life Sciences sector. We look to generate superior investment returns by cultivating value over the long-term. We collaborate with and nurture our portfolio companies. We ensure that every investment we make not only delivers financial returns but brings benefits to humanity, including Malaysia and our surrounding region.
Medical Technologies
Bringing medical innovation to all.
View More
Healthcare Biotech
Reshaping medical standard of care.
View More
Bio Renewables & Bio Industrial
Creating a cleaner world for the future.
View More
Portfolio Highlights
Invendo Medical
Invendo Medical aims to become a globally leading developer and distributor of disposable, highly flexible and easy-to-use endoscopy products in the field of gastroenterology.

Invendo is focussed on an application in the diagnosis and treatment of colorectal cancers (CRC), the second leading cause of cancer death...
Read more
Small Bone Innovations Inc.
The product portfolio of Small Bone Innovations Inc. (SBI), based in Morrisville, Pennsylvania, includes more than 40 devices designed specifically for small bone and joint surgery, such as thumb, wrist, finger, elbow, foot and ankle.

SBI’s product suite has a “star” among its ranks—the Scandinavian Total Ankle Replacement System (the STAR Ankle)...
Read more
ConforMIS Inc.
ConforMIS, founded in 2004 and based in Bedford, Massachusetts, USA, creates personalised, patient-specific implants and disposable instrumentation utilising proprietary imaging technology. The company produces knee systems under the iUni, iDuo and iTotal brands. Each one has received FDA 510(k) clearance and carries the CE, supporting the multi-regional commercial approach...
Read more
News & Events
Passing away of Rashidan Shah, Xeraya's Investment Director
October 27, 2014

It is with profound sadness that Xeraya announces the sudden passing away of Xeraya's Investment Director, Rashidan, a cherished colleague and friend, on the Monday morning of 27th October 2014.

In 2012, Rashidan became one of the first names to come on-board Xeraya. He is without a doubt a key member of our investment team and, by extension, to Xeraya itself given Xeraya’s raison d’etre. With his immense VC/PE and financial industry experience in Malaysia, he has contributed significantly to Xeraya throughout his tenure. His absence will be keenly felt both from a professional level, as well as a personal level, given his cheery and energetic disposition and the genuineness of his personality touching upon various facets of life for those around him. We can only offer our deepest condolences to his beloved family and share their sorrow, as he leaves behind his wife of 18 years and two young sons.

In light of the circumstances, we ask for patience from Xeraya's partners as we shuffle resources around the various priorities.